Meridian Bioscience Inc (VIVO)

A look at the weighted underlying holdings of the WisdomTree US SmallCap Quality Dividend Growth Fund (DGRS) shows an impressive 10.8% of holdings on a weighted basis have experienced insider buying within the past six months. START SLIDESHOW:10 ETFs With Stocks That Insiders Are Buying » Meridian Bioscience Inc.

The most recent short interest data was recently released for the 07/29/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 18.18 "days to cover" versus the median component at 6.42.

Simple, portable diagnostic instrument used in thousands of US clinics will provide three-minute blood lead testing results to Chinese clinicians and parents.

Simple, portable diagnostic instrument used in thousands of US clinics will provide three-minute blood lead testing results to Chinese clinicians and parents

In trading on Friday, shares of Meridian Bioscience Inc. crossed below their 200 day moving average of $19.63, changing hands as low as $19.19 per share.

In recent trading, shares of Meridian Bioscience Inc. have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.13/share.

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 24.46 "days to cover" versus the median component at 6.60.

illumigene® Mycoplasma Direct provides fast and accurate results in less than 1 hour for immediate and targeted treatment

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Meridian Bioscience Inc. were yielding above the 4% mark based on its quarterly dividend (annualized to $0.80), with the stock changing hands as low as $19.96 on the day.

In trading on Tuesday, shares of Meridian Bioscience Inc. crossed below their 200 day moving average of $18.65, changing hands as low as $18.48 per share.

Looking at the universe of stocks we cover at Dividend Channel, on 2/4/16, Meridian Bioscience Inc. , New York REIT Inc , and Capital Bank Financial Corp will all trade ex-dividend for their respective upcoming dividends.

Meridian Bioscience Collaborates With the Centers for Disease Control and Prevention and Cheikh Anta Diop University of Dakar to Launch Diagnostic Test up to 80,000 Times More Sensitive Than Current Options

Investors already know that the multitrillion-dollar health care sector is booming, but these exceptional growth plays in health are largely ignored, which is a great opportunity now for you.

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc.

Stocks with insider trader activity include VIVO, CCG and PDCE

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced it has received clearance from the U.

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has made a minority investment in Oasis Diagnostics ® Corporation ("Oasis"), with the right to acquire Oasis in the future.

Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of Meridian Bioscience Inc. were yielding above the 4% mark based on its quarterly dividend (annualized to $0.80), with the stock changing hands as low as $19.85 on the day.